Back to Journals » OncoTargets and Therapy » Volume 16
Original Research
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,650 | Dovepress* | 3,264+ | 76 | 3,340 | |
PubMed Central* | 386 | 64 | 450 | ||
Totals | 3,650 | 140 | 3,790 | ||
*Since 1 April 2023 |
View citations on PubMed Central and Google Scholar